For anyone making a decision today, the comparison is lopsided in one specific sense: tirzepatide is an option you can actually be prescribed, with an approved label, a regulated supply chain, and accumulating post-market safety data
These multifaceted metabolic effects position dual GLP-1/GIP receptor agonists as superior therapeutic candidates for MASLD, especially in patients with coexisting obesity and T2DM, where dysregulated glucose and lipid metabolism drive the progression of the disease
Research in this area remains limited but emerging evidence provides some guidance
However, the terms of this insurance coverage and any copayments or deductibles associated with it vary. Insurance companies typically have many different plans, each with its own formularyalso known as a prescription drug list (PDL)and its own policies
Common during caloric deficit, especially in the first few weeks
Do not neglect micronutrients